E
E Kaplinsky
Publications - 2
Citations - 304
E Kaplinsky is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Direct thrombin inhibitor. The author has an hindex of 2, co-authored 2 publications receiving 301 citations.
Papers
More filters
Journal ArticleDOI
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients'data
Salim Yusuf,Christopher B. Granger,John W. Eikelboom,Shamir R. Mehta,J Pogue,P Tait,S Behar,M Benderly,Hanoch Hod,E Kaplinsky,N Barrett,R Bilke,M Luz,M Marhoefer,L Roi,D Trenery,John A. Bittl,H Boersma,Marcus Flather,Colin Baigent,Maarten L. Simoons,Robert M. Califf,Karen S. Pieper,Eric J. Topol,Jeff Weitz,Patrick W. Serruys,Harvey D. White,Karl-Ludwig Neuhaus,Uwe Zeymer,John Simes,P Close,Susan Edwards,P Gallo,M Henis,Sonia S. Anand,W Kimball,C Meanwell,J Villiger,Elliott M. Antman,Eugene Braunwald,Michael F. Gibson,Sean P. Murphy,Lars Grip,Peter Held,Trialist Dti. +44 more
TL;DR: Direct thrombin inhibitors are superior to heparin for the prevention of death or myocardial infarction in patients with acute coronary syndromes, and this information should prompt further clinical development of direct throm bin inhibitors for the management of arterial thrombosis.
Journal Article
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens
John R. Downs,Antonio M. Gotto,Michael Clearfield,David Gordon,Teri A. Manolio,U Goldbourt,E Kaplinsky,Lemuel A. Moyé,Frank M. Sacks,Marc A. Pfeffer,C M Hawkins,Eugene Braunwald,MariaGrazia Franzosi,Aldo P. Maggioni,Gianni Tognoni,Sander J. Robins,Hanna Bloomfield Rubins,John Simes,Anthony C Keech,Stephen MacMahon,Andrew Tonkin,Salim Yusuf,Marcus Flather,Rory Collins,Jane Armitage,Colin Baigent,Richard Peto,Peter Sleight,Genell L. Knatterud,John Kjekshus,Terje R. Pedersen,Lars Wilhelmsen,J Roussouw,Jeffrey L. Probstfield,Stuart M. Cobbe,Peter W. Macfarlane,James Shepherd +36 more
TL;DR: By establishing a register of ongoing and planned trials prior to any trial results being known, this systematic overview attempts to avoid the methodologic problems and potential data-dependency of a retrospective project.